The above chart presents the market trend analysis for concord biotech ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 30 transactions, with a transaction quantity of 115568.2 and a transaction weight of 0.
YearTransactionsQuantityWeight
2025303461435.990
202630115568.20
Bill of lading data
<
1/15
>
Trade date
2026/02/24
B/L No.
7725512
Suppliers
amoli middle east fze
Buyers
concord biotech ltd.
Product description
MUPIROCIN USP B NO 0732A424004 MFG DT MAR 2024 RETEST FEB2027 ASPER INV FOC SB NO 3127721DT 28 06 2025MUPIROCIN USP B NO 0732A424004 MFG DT MAR 2024 RETEST FEB
Expand
Product description
ROMIDEPSIN SB NO 3422708 DATE 24 08 2023 B NO 1936A423006MFG DT AUG 2023FOC RE IMPORTING FOR RETESTING PURPOSE ONLYROMIDEPSIN SB NO 3422708 DATE 24 08 2023 B NO 1936A423006 M
Expand
Trade date
2026/02/13
B/L No.
6281632
Suppliers
livzon group ningxia pharmaceutic
Buyers
concord biotech ltd.
concord biotech ltd. is india Buyer&Supplier,
and primarily engages in the import and export business of products such as ice,bat,medicinal.
According to the 52wmb.com global trade database, as of 2026-02-24, the company has completed 11394 international trades,
with its main trading regions covering china,germany,italy etc.
The core products include HS84219900,HS30049099,HS84229090 etc,
often transported via ahemdabad air acc inamd4,port nhava sheva sea innsa1, port nhavasheva jnpt etc,
and its main trading partners are excella expertise sino ltd,turking technology limited,truking technologies ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on concord biotech ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.